Author

Xitlally Popa

Institution: Center of Molecular Immunology (Cuba)

Observed institution: Center of Molecular Immunology (Cuba)

OpenAlex ID: A5113701571

Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients

2015 · Danay Saavedra, Beatriz García, et al. · Cancer Immunology Immunotherapy · 74

Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients

2011 · Pedro C Rodriguez, Elia Neninger, et al. · Journal of Immune Based Therapies and Vaccines · 32

Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule

2020 · Xitlally Popa, Beatriz García, et al. · OncoImmunology · 16

EGF-based cancer vaccine: Optimizing predictive and surrogate biomarkers.

2013 · Tania Crombet Ramos, Elia Neninger, et al. · Journal of Clinical Oncology · 6

EGF-based cancer vaccine for advanced NSCLC: Results from a phase III trial.

2012 · Tania Crombet Ramos, Elia Neninger, et al. · Journal of Clinical Oncology · 4

P2.34: Vaxira and CIMAvax-EGF Therapeutic Vaccines Combination in the Advanced NSCLC Treatment

2016 · Amparo E. Macias, Ramon Ortiz, et al. · Journal of Thoracic Oncology · 2

Her1 vaccine for epithelial tumors therapy: primeboosting strategy based on lentiviral-protein vaccination to potentiate the vaccine effect

2012 · Belinda Sánchez-Ramírez, Yeranddy A. Alpízar, et al.

Works count: 7

Citation count: 134

H-index: 4

I10-index: 3